A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus.
Bhanu Prasad VenkatesuluViveksandeep Thoguluva ChandrasekarPrashanth GirdharPragati AdvaniAmrish SharmaThiraviyam ElumalaiRodney Cheng-En HsiehHagar I ElghazawyVivek VermaKrishnan SunilPublished in: JNCI cancer spectrum (2021)
Cancer patients with COVID-19 disease are at increased risk of mortality and morbidity. A more nuanced understanding of the interaction between cancer-directed therapies and COVID-19-directed therapies is needed. This will require uniform prospective recording of data, possibly in multi-institutional registry databases.